2023 September Life Sciences Update

Drugs and Therapies Aimed at an Aging Population Will Drive Life Sciences Innovation

› Globally, the proportion of adults aged 65 and older is growing at a faster rate than other age groups. The current population of 65 and older grew 27% since 2015 and is forecast to grow an additional 25% through 2030. › Currently, there are over 400 medicines and therapies in development aimed at targeting chronic diseases impacting older Americans, according to PhRMA. Additionally, there are also over 800 active clinical trials focused on aging according to the National Institutes of Health (NIH) database.

Global Population by Age Group

Ages 0-14 Ages 15-64 Ages 65 and greater

2000

27%

66%

8%

2005

25%

67%

8%

2010

23%

68%

9%

Key Takeaway: Underlying demographic needs will continue to drive long-term growth in life sciences.

2015

23%

68%

10%

2020

22%

67%

11%

2023 Q2

21%

67%

12%

2025 Forecast

20%

67%

12%

2030 Forecast

19%

67%

14%

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

Source: Moody’s Analytics

5 / CUSHMAN & WAKEFIELD

LIFE SCIENCES SEPTEMBER 2023